Stock PPLPHARMA PIRAMAL PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Piramal Pharma Limited

Equities

PPLPHARMA

INE0DK501011

Market Closed - NSE India S.E.
Other stock markets
 07:43:53 2024-05-27 EDT 		5-day change 1st Jan Change
149.7 INR +1.39% Intraday chart for Piramal Pharma Limited +0.13% +7.81%
05-14 Jefferies Adjusts Piramal Pharma’s Price Target to INR180 From INR170, Keeps at Buy MT
05-13 Transcript : Piramal Pharma Limited, Q4 2024 Earnings Call, May 13, 2024

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Jefferies Adjusts Piramal Pharma’s Price Target to INR180 From INR170, Keeps at Buy
MT
Transcript : Piramal Pharma Limited, Q4 2024 Earnings Call, May 13, 2024
Piramal Pharma Limited Announces Results for Q4 and FY2024
AQ
Piramal Pharma Limited Announces Resignation of Nathalie Leitch as Non-Executive, Non-Independent Director
CI
Piramal Pharma Limited Recommends Final Dividend for the Financial Year Ended 31 March 2024
CI
Piramal Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2024
CI
Piramal Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
CI
Piramal Pharma Limited Receives Assessment Orders from the Office of the Navi Mumbai Municipal Corporation, Cess Department
CI
Piramal Pharma Limited Receives Order from the Regional Provident Fund Commissioner, Thane South, Levying Damages of INR 1,120,932 Under Bombay Provincial Municipal Corporation (Cess on Entry of Goods) Rules, 1996
CI
Piramal Pharma Gets US FDA's Establishment Inspection Report for Riverview, US Facility
MT
Piramal Pharma Forays into Men Grooming Products
MT
Piramal Pharma Limited Announces the Launch of BOHEM Product Range
CI
Transcript : Piramal Pharma Limited, Q3 2024 Earnings Call, Jan 31, 2024
Piramal Pharma Turns to Profit in Fiscal Q3
MT
Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2024
AQ
Piramal Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
PIRAMAL PHARMA SOLUTIONS COMMEMORATES OPENING OF ITS ADC MANUFACTURING EXPANSION IN GRANGEMOUTH, SCOTLAND
AQ
Piramal Pharma Solutions Commences Opening of Its Antibody-Drug Conjugate Manufacturing Expansion in Grangemouth, Scotland
CI
FOCUS -Indian drug manufacturers benefit from Big Pharma interest beyond China
RE
Piramal Pharma Gets US FDA's EIR Report After Bethlehem, USA Unit Inspection
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PPLPHARMA Stock
  4. News Piramal Pharma Limited